Takeshi Kajiwara

A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study.

Ken Kato, Yoshinori Ito, Hiroyuki Daiko et al. · Journal of Clinical Oncology · 2022 · 193 citations

Medicine, Oncology, Radiation Oncology +17

TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study

Yasutoshi Kuboki, Tomohiro Nishina, Eiji Shinozaki et al. · The Lancet Oncology · 2017 · 175 citations

Medicine, Oncology, Pharmacology +9

Anti-HBs-Positive Liver Failure Due to Hepatitis B Virus Reactivation Induced by Rituximab

Toshiki Sera, Yoichi Hiasa, Kojiro Michitaka et al. · Internal Medicine · 2006 · 127 citations · Full text

Medicine, Hematology, Immunology +17

Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study

Toshikazu Moriwaki, Shota Fukuoka, Hiroya Taniguchi et al. · The Oncologist · 2017 · 105 citations · Full text

Medicine, Oncology, Pharmacology +12

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer

J Matsubara, Tomohiro Nishina, Yosuke Yamada et al. · British Journal of Cancer · 2008 · 95 citations · Full text

Medicine, Cancer Biology, Oncology +16